One week ago, we concluded the AMMF 2024 European CCA Conference. From exciting research updates from the frontline of CCA advancements to thought-provoking patient insights, all our sessions are now available to stream on demand!
#LiverTwitter #AMMF2024

A special shoutout to our incredible patient speakers at #AMMF2024 – Andy Clay, Benjamin Carey, Ilona Smith, and Gareth Honeybone – who shared incredible stories from throughout their CCA journeys. Their perspectives inspire us all to create a better future for the CCA community

An excellent conference in London organized by AMMF on cancers in the bile duct where insights on the diseases were shared. I was especially impressed by the Thai effort in reducing the risk of liver fluke infection in SE Asia.

Our CEO and Founder - Helen Morement - would like to extend her sincerest gratitude to the speakers, attendees, poster presenters, and sponsors who helped make this year’s European CCA Conference such a success. We look forward to welcoming you all again in 2025 #AMMF2024

Did you know that #AMMF has a European Website?

The European website provides information and support to those who need it, in 8 different languages, with more to come.

Explore here: ammf-eu.org

#bileductcancer #cholangiocarcinoma

We would once again like to thank all of our attendees for their support for this year’s AMMF European CCA Conference. It is always an honour to bring together passionate individuals who are united in the goal of improving quality of life for people living with CCA #AMMF2024

We would like to thank all sponsors of #AMMF ’s Hybrid 2024 European #Cholangiocarcinoma Conference: AstraZeneca Jazz Pharmaceuticals Taiho Oncology Servier and TransThera Sciences. We look forward to future partnerships.

#AMMF 2024 #LiverTwitter #cholangiocarcinoma

Thank you to all attendants, participants, and supporters of #AMMF ’s Hybrid 2024 European #Cholangiocarcinoma Conference. We hope you benefited from the conference and we look forward to seeing you again next year!

#AMMF 2024 #LiverTwitter #bileductcancer

AMMF would like to congratulate Dr. Colin Rae from University of Glasgow who was awarded best poster for: ‘Establishment of 3-dimensional organoids from biliary cancers’. Thanks to all of our wonderful delegates who shared their research at AMMF’s European CCA Conference #AMMF2024

In the final basic research update at #AMMF20204 , Dr. Isioma Egbuniwe (Isioma Egbuniwe MBBS PhD) of Uni of Nottingham #WeAreUoN discussed her AMMF-funded research on ultra high-resolution mapping of gene and protein expression patterns in CCA and its tumour microenvironment  #LiverTwitter

AMMF-funded research: Francesco Amato (Francesco Amato) from University of Glasgow presented their research investigating the role of monocytes in modulating chemotherapy responses in biliary tract cancer #AMMF2024   #LiverTwitter

Cholangiocarcinoma on chip! Dr. Michela Polidoro (Michela Polidoro) from Humanitas Milano shared her fascinating research on developing a microfluid model that mimics the in-vivo-like CCA microenvironment #AMMF2024 #LiverTwitter

Prof. Rocío Macias (Rocío IR Macías) from IBSAL gave an insightful presentation on her research into transport proteins, discussing how certain transport proteins can be used to help in the diagnosis and prognosis of CCA, as well as predicting responses to chemotherapy #AMMF2024

Engaging Q&A session following insightful CCA research presentations. Great interaction and exchange of ideas!

Mr. Marc Quinn from University of Liverpool discussed the findings from his AMMF-funded research on BRCA splice-site mutations in perihilar CCA #AMMF2024 #cholangiocarcinoma

Fascinating insights from Prof. Stephanie Roessler from Universitätsklinikum Heidelberg on the genetic and epigenetic alterations involved in CCA development #AMMF2024 #LiverTwitter

Dr. Micol Damiani from Imperial College London presented her research on developing a nanopore-based sensor for detecting miRNA biomarkers in CCA and HCC and discussed the challenges in detecting miRNA in clinical samples. AMMF are proud to sponsor this exciting research project!

AMMF-funded research by Dr. Veronica Porreca of Sapienza Università di Roma reveals: thrombospondin 1 (THBS1) & 2 (THBS2) promote malignant behaviour of iCCA cells, while pigment epithelium-derived factor (PEDF) does not affect iCCA cell proliferation and reduces cell adhesion and migration

Engaging impromptu Q&A session at #AMMF2024 focused on the ethical considerations of using tissue samples for secondary research purposes. A deep dive into the implications for consent and patient rights

Dr. Tim Kendall from The University of Edinburgh asked, 'What can we do to maximise what we have?' emphasising the need to use tissue in research. Tissue-derived information is increasingly necessary for personalised treatment #AMMF2024 #LiverTwitter #cholangiocarcinoma